Abstract
Within 5 years of the isolation of the serum vasoconstrictor factor, 5-hydroxytryptamine (5-HT), its vasodilating properties had been recognized; Haddy (1953) described 5-HT-induced vasodilation in the forelimb in anaesthetized dogs. A real understanding of the mechanisms responsible for the vasodilator effects of 5-HT, however, has taken a much longer time to emerge.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Angus, J. A., Cocks, T. M. and Wright, C. E. (1987). Mechanisms of 5-HT induced vasospasm and vasodilatation in large and small arteries. Clin. Exp. Pharmacol. Physiol., Suppl. 11, 20
Bevan, J. A., Duckies, S. P. and Lee, T. J.-F. (1975). Histamine potentiation of nerve- and drug-induced responses of a rabbit cerebral artery. Circ. Res., 36, 647–653
Blackshear, J. L., Orlandi, C., Garnic, J. D. and Hollenberg, N. K. (1985). Differential large and small vessel responses to serotonin in the dog hindlimb in vivo: role of the 5-HT2 receptor. J. Cardiovasc. Pharmacol., 7, 42–49
Bradley, P. B., Engel, G., Feniuk, W., Fozard, J. R., Humphrey, P. P. A., Middlemiss, D. N., Mylecharane, E. J., Richardson, B. P. and Saxena, P. R. (1986). Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology, 25, 563–576
Chand, N. (1981). 5-Hydroxytryptamine induces relaxation of goat pulmonary veins: evidence for the noninvolvement of M and D-tryptamine receptors. Br. J. Pharmacol., 72, 233–237
Charlton, K. G., Bond, R. A. and Clarke, D. E. (1986). An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney: apparent distinction from the 5-HT1A, 5-HT1B and 5-HT1C subtypes. Naunyn-Schmiedeberg’s Arch. Pharmacol., 332, 8–15
Cocks, T. M. and Angus, J. A. (1983). Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature, 305, 627–630
Cohen, R. A., Shepherd, J. T. and Vanhoutte, P. M. (1983). 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. Am. J. Physiol., 245, H1077–H1080
Edvinsson, L., Hardebo, J. E. and Owman, Ch. (1978). Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man. Circ. Res., 42, 143–151
Engel, G., Göthert, M., Müller-Schweinitzer, E., Schlicker, E., Sistonen, L. and Stadler, P. A. (1983). Evidence for common pharmacological properties of [3H]-5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine auto-receptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Naunyn-Schmiedeberg’s Arch. Pharmacol., 324, 116–124
Eyre, P. (1975). Atypical tryptamine receptors in sheep pulmonary vein. Br. J. Pharmacol., 55, 329–333
Feniuk, W., Humphrey, P. P. A. and Watts, A. D. (1979). Presynaptic inhibitory action of 5-hydroxytryptamine in dog isolated saphenous vein. Br. J. Pharmacol., 67, 247–254
Feniuk, W., Humphrey, P. P. A. and Watts, A. D. (1981). Modification of the vasomotor actions of methysergide in the femoral arterial bed of the anaesthetized dog by changes in sympathetic nerve activity. J. Auton. Pharmacol., 1, 127–132
Feniuk, W., Humphrey, P. P. A. and Watts, A. D. (1983). 5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. Eur. J. Pharmacol., 96, 71–78
Fishburn, P. A., Phillips, C. A. and Mylecharane, E. J. (1987). 5-Hydroxytryptamine-induced inhibition of [3H]-noradrenaline overflow responses in transmurally stimulated dog saphenous vein preparations. Clin. Exp. Pharmacol. Physiol, Suppl. 10, 72
Furchgott, R. F. and Zawadzki, J. V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373–376
Garattini, S. and Valzelli, L. (1965). Serotonin, Elsevier, Amsterdam, pp. 169–198
Göthert, M., Kollecker, P., Rohm, N. and Zerkowski, H.-R. (1986a). Inhibitory presynaptic 5-hydroxytryptamine (5-HT) receptors on the sympathetic nerves of the human saphenous vein. Naunyn-Schmiedeberg’s Arch. Pharmacol., 332, 317–323
Göthert, M., Schlicker, E. and Kollecker, P. (1986b). Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in the rat vena cava and in the heart of the pithed rat. Naunyn-Schmiedeberg’s Arch. Pharmacol., 332, 124–130
Haddy, F. J. (1953). Physiological studies of the venous system. Unpublished Ph.D. thesis, University of Minnesota
Haddy, F. J., Gordon, P. and Emanuel, D. A. (1959). The influence of tone upon responses of small and large vessels to serotonin. Circ. Res., 7, 123–130
Kalkman, H. O., Boddeke, H. W. G. M., Doods, H. N., Timmermans, P.B.M. W. M. and van Zwieten, P. A. (1983). Hypotensive activity of serotonin receptor agonists in rats is related to their affinity for 5-HT1 receptors. Eur. J. Pharmacol., 91, 155–156
McCubbin, J. W., Kaneko, Y. and Page, I. H. (1962). Inhibition of neurogenic vasoconstriction by serotonin. Circ. Res., 11, 74–83
McGrath, M. A. (1977). 5-Hydroxytryptamine and neurotransmitter release in canine blood vessels: inhibition by low and augmentation by high concentrations. Circ. Res., 41, 428–435
Markus, J. K., Phillips, C. A. and Mylecharane, E. J. (1989a). Receptor mechanisms involved in the pre-synaptic sympathetic inhibitory action of 5-hydroxytryptamine in the dog common carotid arterial circulation. Eur. J. Pharmacol. (submitted for publication)
Markus, J. K., Phillips, C. A., Mylecharane, E. J, and Shaw, J. (1989b). The mechanism of the vasodilator action of 5-hydroxytryptamine in the dog common carotid arterial circulation in vivo. Eur. J. Pharmacol. (submitted for publication)
Martin, G. R., Leff, P., Cambridge, D. and Barrett, V. J. (1987). Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines. Naunyn-Schmiedeberg’s Arch. Pharmacol., 336, 365–373
Mena, M. A. and Vidrio, H. (1979). Reversal of serotonin vasodilatation in the dog external carotid bed by sympathetic denervation. J. Cardiovasc. Pharmacol., 1, 149–154
Molderings, G. J., Fink, K., Schlicker, E. and Göthert, M. (1987). Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava. Naunyn Schmiedeberg’s Arch. Pharmacol., 336, 245–250
Müller-Schweinitzer, E. (1981). Agonist potencies of tryptamine derivatives at pre-and postjunctional receptors in canine saphenous vein. Postgrad. Med. J., 57, Suppl. 1, 36–44
Mylecharane, E. J. and Phillips, C. A. (1987). 5-HT1-like receptor-mediated pre-synaptic sympathetic inhibition in the dog common carotid arterial circulation. Clin. Exp. Pharmacol. Physiol., Suppl. 11, 30
Mylecharane, E. J., Spira, P. J., Misbach, J., Duckworth, J. W. and Lance, J. W. (1978). Effects of methysergide, pizotifen and ergotamine in the monkey cranial circulation. Eur. J. Pharmacol., 48, 1–9
Mylecharane, E. J., Duckworth, J. W., Lord, G. D. A. and Lance, J. W. (1980). Effects of low doses of clonidine in the monkey cranial circulation. Eur. J. Pharmacol., 68, 163–173
Phillips, C. A. and Mylecharane, E. J. (1987). The actions of 5-hydroxytryptamine in the external carotid circulation of the monkey. Clin. Exp. Pharmacol. Physiol., Suppl. 11, 188
Phillips, C. A., Mylecharane, E. J., Markus, J. K. and Shaw, J. (1985a). Hypotensive actions of ketanserin in dogs: involvement of a centrally mediated inhibition of sympathetic vascular tone. Eur. J. Pharmacol., 111, 319–327
Phillips, C. A., Mylecharane, E. J. and Shaw, J. (1985b). Mechanisms involved in the vasodilator action of 5-hydroxytryptamine in the dog femoral arterial circulation in vivo. Eur. J. Pharmacol., 113, 325–334
Saxena, P. R. (1972). The effects of antimigraine drugs on the vascular responses by 5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: possible pharmacological implications to their antimigraine action. Headache, 12, 44–54
Saxena, P. R. and Verdouw, P. D. (1982). Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow. J. Physiol., 332, 501–520
Spira, P. J., Mylecharane, E. J., Misbach, J., Duckworth, J. W. and Lance, J. W. (1978). Internal and external carotid vascular responses to vasoactive agents in the monkey. Neurology, 28, 162–173
Su, C. and Uruno, T. (1985). Excitatory and inhibitory effects of 5-hydroxytryptamine in mesenteric arteries of spontaneously hypertensive rats. Eur. J. Pharmacol., 106, 283–290
Swank, R. L. and Hissen, W. (1964). Influence of serotonin on cerebral circulation. Arch. Neurol., 10, 468–472
Trevethick, M. A., Feniuk, W. and Humphrey, P. P. A. (1984). 5-Hydroxytryptamine-induced relaxation of neonatal porcine vena cava in vitro. Life Sci., 35, 477–486
Van Nueten, J. M., Janssen, P. A. J., Van Beek, J., Xhonneux, R., Verbeuren, T. J. and Vanhoutte, P. M. (1981). Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. J. Pharmacol. Exp. Ther., 218, 217–230
Vidrio, H. and Hong, E. (1976). Vascular tone and reactivity to serotonin in the internal and external carotid vascular beds of the dog. J. Pharmacol Exp. Ther., 197, 49–56
Watts, A.D., Feniuk, W. and Humphrey, P. P. A. (1981). A pre-junctional action of 5-hydroxytryptamine and methysergide on noradrenergic nerves in dog isolated saphenous vein. J. Pharm. Pharmacol., 33, 515–520
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1989 The editors and contributors
About this chapter
Cite this chapter
Mylecharane, E.J., Phillips, C.A. (1989). Pre-synaptic Sympathetic Inhibition and 5-Hydroxytryptamine-induced Vasodilatation. In: Mylecharane, E.J., Angus, J.A., de la Lande, I.S., Humphrey, P.P.A. (eds) Serotonin. Satellite Symposia of the IUPHAR 10th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-10114-6_18
Download citation
DOI: https://doi.org/10.1007/978-1-349-10114-6_18
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-10116-0
Online ISBN: 978-1-349-10114-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)